MEGAN LUNA: Open Payments
NPI 1760071773 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 23 payments from 6 companies in 2025. Trend: 2023 $1,011 · 2024 $1,041 · 2025 $509
Food & beverage: $472Education: $37
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 11 | $258 |
| Merck Sharp & Dohme LLC | 8 | $167 |
| EMD Serono, Inc. | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Napo Pharmaceuticals Inc | 1 | $17 |
Products named: CABENUVA, APRETUDE, ZERBAXA, PIFELTRO, DALVANCE, Mytesi.
Industry payments across NV — which companies pay providers there.
